Skip to content

Clinical study of endovascular treament for acute large artery occlusion ischemci stroke

Clinical study of endovascular treament for acute large artery occlusion stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091546
Enrollment
Unknown
Registered
2024-10-30
Start date
2024-10-30
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebrovascular disease

Interventions

Sponsors

First Affiliated Hospital of Hainan Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years; 2. Clinical symptoms and signs support acute ischemic stroke, and NIHSS score=2; 3. Presentation within 24 hours, acute large artery occlusion comfirmed by CTA, MRA or DSA; 4. Presentation within modified Rankin Scale (mRS) score<2;

Exclusion criteria

Exclusion criteria: 1. Neuroimaging evidence of cerebral hemorrhage on presentation; 2. Allergy to contrast media; 3. Active bleeding; genetic or acquired bleeding predisposition, deficiency of anticoagulant factors; 4. Current pregnancy or lactation; 5. A serious, advanced, or terminal illness; 6. A lack of follow-up information on outcomes at 90 days; 7. Incomplete baseline imaging and time-metric data.

Design outcomes

Primary

MeasureTime frame
90-days good functional outcome;The rate of sICH within 48 hours and 90-days mortality;

Countries

China

Contacts

Public ContactLi Wei

First Affiliated Hospital of Hainan Medical University

weiligysy@163.com+86 189 7657 4937

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026